HbA1c was 65mmol/mol ( 95 % CI 60 , 71 ) at the end of the SC treatment phase in 2006 , 58mmol/mol ( 95 % CI 53 , 64 ) at the end of the CIPII treatment phase and 65mmol/mol ( 95 % CI 60 , 71 ) in 2012 , respectively ( p > 0.05 ) .